Here are the 16 companies in Jefferson Innovation’s portfolio, according to its website:
- BioVaxys
- Bound Therapeutics
- BrachyThermix
- Capillary Biomedical
- Circalux
- Clementia
- Conatus Pharmaceuticals
- Immunome
- Imvax
- MTTI
- NuView Life Sciences
- RTM Vital Signs
- Sonogen Medical
- Sillajen
- Targeted Diagnostics & Therapeutics
- Xilio Therapeutics
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
